Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study

O. Caffo; E. Biasco; G. Facchini; L. Fratino; D. Gasparro; C. Mosillo; U. Basso; D. Santini; M. Tucci; C. Ortega; F. Verderame; S. Scagliarini; G. L.O. Re; G. Procopio; G. Fornarini; E. Campadelli; R. Sabbatini; F. Maines; U. De Giorgi

doi:10.1093/annonc/mdw372.27

Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study

O. Caffo, E. Biasco, G. Facchini, L. Fratino, D. Gasparro, C. Mosillo, U. Basso, D. Santini, M. Tucci, C. Ortega, F. Verderame, S. Scagliarini, G. L.O. Re, G. Procopio, G. Fornarini, E. Campadelli, R. Sabbatini, F. Maines, U. De Giorgi

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	vi252
Journal	Annals of Oncology
Volume	27
DOIs	https://doi.org/10.1093/annonc/mdw372.27
Publication status	Published - Oct 1 2016

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdw372.27

Cite this

Caffo, O., Biasco, E., Facchini, G., Fratino, L., Gasparro, D., Mosillo, C., Basso, U., Santini, D., Tucci, M., Ortega, C., Verderame, F., Scagliarini, S., Re, G. L. O., Procopio, G., Fornarini, G., Campadelli, E., Sabbatini, R., Maines, F., & De Giorgi, U. (2016). Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study. Annals of Oncology, 27, vi252. https://doi.org/10.1093/annonc/mdw372.27

Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study. / Caffo, O.; Biasco, E.; Facchini, G.; Fratino, L.; Gasparro, D.; Mosillo, C.; Basso, U.; Santini, D.; Tucci, M.; Ortega, C.; Verderame, F.; Scagliarini, S.; Re, G. L.O.; Procopio, G.; Fornarini, G.; Campadelli, E.; Sabbatini, R.; Maines, F.; De Giorgi, U.

In: Annals of Oncology, Vol. 27, 01.10.2016, p. vi252.

Research output: Contribution to journal › Article › peer-review

Caffo, O, Biasco, E, Facchini, G , Fratino, L, Gasparro, D, Mosillo, C, Basso, U, Santini, D, Tucci, M, Ortega, C, Verderame, F, Scagliarini, S, Re, GLO, Procopio, G , Fornarini, G, Campadelli, E, Sabbatini, R, Maines, F & De Giorgi, U 2016, 'Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study', Annals of Oncology, vol. 27, pp. vi252. https://doi.org/10.1093/annonc/mdw372.27

Caffo O, Biasco E, Facchini G , Fratino L, Gasparro D, Mosillo C et al. Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study. Annals of Oncology. 2016 Oct 1;27:vi252. https://doi.org/10.1093/annonc/mdw372.27

Caffo, O. ; Biasco, E. ; Facchini, G. ; Fratino, L. ; Gasparro, D. ; Mosillo, C. ; Basso, U. ; Santini, D. ; Tucci, M. ; Ortega, C. ; Verderame, F. ; Scagliarini, S. ; Re, G. L.O. ; Procopio, G. ; Fornarini, G. ; Campadelli, E. ; Sabbatini, R. ; Maines, F. ; De Giorgi, U. / Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study. In: Annals of Oncology. 2016 ; Vol. 27. pp. vi252.

@article{a5919afb1c204bb2a329519d1fb6b9bc,

title = "Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study",

author = "O. Caffo and E. Biasco and G. Facchini and L. Fratino and D. Gasparro and C. Mosillo and U. Basso and D. Santini and M. Tucci and C. Ortega and F. Verderame and S. Scagliarini and Re, {G. L.O.} and G. Procopio and G. Fornarini and E. Campadelli and R. Sabbatini and F. Maines and {De Giorgi}, U.",

year = "2016",

month = oct,

day = "1",

doi = "10.1093/annonc/mdw372.27",

language = "English",

volume = "27",

pages = "vi252",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

}

TY - JOUR

T1 - Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study

AU - Caffo, O.

AU - Biasco, E.

AU - Facchini, G.

AU - Fratino, L.

AU - Gasparro, D.

AU - Mosillo, C.

AU - Basso, U.

AU - Santini, D.

AU - Tucci, M.

AU - Ortega, C.

AU - Verderame, F.

AU - Scagliarini, S.

AU - Re, G. L.O.

AU - Procopio, G.

AU - Fornarini, G.

AU - Campadelli, E.

AU - Sabbatini, R.

AU - Maines, F.

AU - De Giorgi, U.

PY - 2016/10/1

Y1 - 2016/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081656912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081656912&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdw372.27

DO - 10.1093/annonc/mdw372.27

M3 - Article

VL - 27

SP - vi252

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -